Invited Commentary: Cancer and COVID: Sailing Uncharted Seas DOI
Mark R. Katlic

Journal of the American College of Surgeons, Journal Year: 2023, Volume and Issue: 237(3), P. 430 - 432

Published: June 1, 2023

Language: Английский

A National Laboratory Perspective: The Impact of the Covid-19 Pandemic on the Management of Patients With Non-Communicable Disease in South Africa: Impact of COVID-19 on patients with noncommunicable diseases DOI Creative Commons
E C Kruger,

Diederick J van der Westhuizen,

Rajiv T. Erasmus

et al.

Disaster Medicine and Public Health Preparedness, Journal Year: 2024, Volume and Issue: 18

Published: Jan. 1, 2024

Abstract Objective: The aim of this study was to determine the impact COVID-19 pandemic on test requests for diagnosis and routine care patients with various non-communicable diseases (NCD) across South Africa (SA). Methods: A retrospective audit laboratory received from hospital outpatient departments primary healthcare facilities SA performed. following analytes were studied: glycated hemoglobin (HbA1c), lipids profiles, thyroid-stimulating hormone (TSH), thyroxine (fT4), as well triiodothyronine (fT3), serum protein electrophoresis (SPE), free light chains (SFLC), prostate specific antigen (PSA); these tests used a proxy NCD detection follow-up. Requests during 3 waves compared within same period 2017 - 2019. Results: During first wave, all reduced, biggest reduction observed SPE (− 37%); TSH 29%); fT4 28%); HbA1c 25%). urban showed larger decrease those rural facilities. third wave there an increase in analytes; fT3 (21%) (18%). Conclusions: had significant African population receiving public sector.

Language: Английский

Citations

1
COVID-19 Pandemic–Related Outcomes in High-Risk Gastrointestinal Cancers—Beyond the Numbers DOI Creative Commons
Hadley D. Freeman,

Aaron Saunders,

Sharon S. Lum

et al.

JAMA Network Open, Journal Year: 2024, Volume and Issue: 7(3), P. e240143 - e240143

Published: March 5, 2024

Lauren M. Janczewski, MD, MS; Amanda E. Browner, Joseph H. Cotler, PhD; Bryan Palis, MA; Kelley Chan, MD; Rachel Joung, David J. Bentrem, Ryan P. Merkow, Daniel Boffa, MBA; Heidi Nelson, MD

Language: Английский

Citations

1
Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic DOI Creative Commons
Connor J. Kinslow,

David DeStephano,

Alfred I. Neugut

et al.

JNCI Cancer Spectrum, Journal Year: 2024, Volume and Issue: 8(3)

Published: March 21, 2024

The COVID-19 pandemic caused widespread disruptions in cancer care. We hypothesized that the greatest diagnosis occurred screen-detected cancers. identified patients (≥18 years of age) with newly diagnosed from 2019 to 2020 US National Cancer Database and calculated change proportion early-stage late-stage cancers using a weighted linear regression. Disruptions were greater than (17% vs 12.5%). Melanoma demonstrated relative decrease (22.9% 9.2%), whereas was similar for pancreatic cancer. Compared breast cancer, cervical, melanoma, prostate, colorectal, lung showed diagnosis. Uninsured experienced privately insured patients. had larger impact on disease, particularly Our study supports emerging evidence primary care visits may play critical role early melanoma detection.

Language: Английский

Citations

1
Rates of newly diagnosed breast cancer at commission on cancer facilities during the early phase of the COVID‐19 pandemic DOI Creative Commons
Marie Fefferman, Kristine Kuchta,

Chi‐Hsiung Wang

et al.

Cancer Medicine, Journal Year: 2023, Volume and Issue: 13(1)

Published: Dec. 22, 2023

The objective of this study was to examine the impact early part COVID-19 pandemic on number newly diagnosed breast cancer cases at Commission Cancer (CoC)-accredited facilities relative United States (U.S.) population.

Language: Английский

Citations

3
Pandemic-Related Changes in Incidence and Mortality Rates of Gastrointestinal Cancers During 2020 DOI
Caitlin C. Murphy, Anna Tavakkoli, Sachin Wani

et al.

The American Journal of Gastroenterology, Journal Year: 2023, Volume and Issue: unknown

Published: Oct. 4, 2023

INTRODUCTION: Coronavirus Disease 2019 disrupted cancer-related care in early 2020. METHODS: We used population-based cancer registry data to estimate incidence and mortality rates of gastrointestinal cancers between 2016 RESULTS: Incidence were unchanged from but decreased 2020, with the largest declines for colorectal (rate ratio [RR] 0.88; 95% confidence interval [CI] 0.87–0.90) hepatocellular carcinoma (RR 0.85; CI 0.82–0.88). Mortality 1.06; 1.04–1.08) esophageal adenocarcinoma 1.00–1.13) increased DISCUSSION: may increase future given pandemic-related delays

Language: Английский

Citations

2
COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States DOI Creative Commons
Bhupinder Kaur, Yee Hui Yeo, Jeff Liang

et al.

Gastro Hep Advances, Journal Year: 2023, Volume and Issue: 3(2), P. 230 - 237

Published: Nov. 23, 2023

The change in hepatocellular carcinoma (HCC) care continuum during the coronavirus disease 2019 (COVID-19) pandemic remains unknown at a national level United States. We sought to determine impact of on incident HCC cases, clinical characteristics, and treatment

Language: Английский

Citations

2
COVID‐19 destabilized usual patterns of cancer care DOI Open Access

Mary Beth Nierengarten

Cancer, Journal Year: 2023, Volume and Issue: 129(18), P. 2763 - 2764

Published: Aug. 18, 2023

Data from the National Cancer Database (NCDB) collected during first year of pandemic in 2020 show that destabilized usual patterns cancer care, with 14% fewer new diagnoses reported versus 2019 according to a study published JAMA Surgery.1 In actual numbers, this represents more than 200,000 cases not diagnosed or treated at nearly 1500 Commission on Cancer–accredited programs use NCDB data for quality assurance purposes. The lead author study, Sharon S. Lum, MD, MBA, chair Department Surgery and Clifton Sandra Reeves Chair General Loma Linda University California, says results were expected because restrictions implemented pandemic. Also was significant increase found observed-to-expected proportion stage IV (16.7% vs. 16.0%; p < .05). What surprising, Dr these trends varied specific types. For digestive system cancers, example, decrease observedto-expected I (17.1% 17.8%; .001 both) an (27.9% 26.6%; both). breast cancer, other hand, significantly increased (56.4% 54.1%; both), decreased (4.6% 4.8%; Investigators undertook better understand impact captured registry validate report disruption data, which are historically stable. included adults (18 years old older) who and/or underwent course treatment January 2018 through December 2020. used things such as improvement, hospital benchmarking, accreditation research, underscores all ensuing reports analyses survival will be affected unusual care “We have yet seen full patients whether it infection virus collateral damage people coming normal care,” she says, emphasizing need watch did come oncologists plan using any purposes mentioned previously, recommends, stated acknowledging aberration follows: “This includes 2020, COVID-19 Variability reporting must considered when interpreting results.”

Language: Английский

Citations

1
National Cancer Database Reports Ongoing Disruptions in Cancer Diagnoses in 2021 DOI
Lauren M. Janczewski,

Amanda E. Browner,

Joseph Cotler

et al.

Annals of Surgical Oncology, Journal Year: 2023, Volume and Issue: 31(2), P. 729 - 730

Published: Dec. 7, 2023

Language: Английский

Citations

1
Fragmentation of Care in Breast Cancer: Greater than the Sum of its Parts DOI Creative Commons
Hadley D. Freeman,

Linnea C. Burke,

Ja’Neil G. Humphrey

et al.

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: June 5, 2024

Abstract INTRODUCTION: Fragmentation of care (FC, the receipt at > 1 institution) has been shown to negatively impact cancer outcomes. Given multimodal nature breast treatment, we sought identify factors associated with FC and its effects on survival patients. METHODS: A retrospective analysis was performed surgically treated, stage I-III patients in 2004–2020 National Cancer Database, excluding neoadjuvant therapy recipients. Patients were stratified into two groups: or non-FC care. Treatment delay defined as definitive surgery 60 days after diagnosis. Multivariable logistic regression predictive FC, compared using Kaplan-Meier multivariable Cox proportional hazards methods. RESULTS: Of 531,644 identified, 340,297 (64.0%) received FC. After adjustment, (OR 1.27, 95% CI 1.25–1.29) independently treatment delay. Factors included Hispanic ethnicity 1.04, CI: 1.01–1.07), comprehensive community programs 1.06, 1.03–1.08) integrated network 1.55, 1.51–1.59), AJCC II 1.05–1.07) III tumors 1.02–1.10), HR+/HER2 + 1.05, 1.02–1.07). increased risk mortality (HR 1.23, 1.20–1.26), whereas 0.87, 0.86–0.88) showed benefit. CONCLUSIONS: While impacts patients, our findings suggest could be a marker for multispecialty that may mitigate some these effects.

Language: Английский

Citations

0
Risk factors of a positive resection margin in locoregional appendix cancer and its impact on survival: The national cancer database analysis DOI Creative Commons
Ekaterina Baron, Chih‐Ching Wu, Andrei Nikiforchin

et al.

Surgical Oncology Insight, Journal Year: 2024, Volume and Issue: 1(3), P. 100072 - 100072

Published: June 26, 2024

Language: Английский

Citations

0